Cargando…
Influence of xanthine oxidoreductase inhibitor, topiroxostat, on body weight of diabetic obese mice
Plasma xanthine oxidoreductase (XOR) activity is high in metabolic disorders such as diabetic mellitus, obesity, or overweight. Thus, this study investigated whether the XOR inhibitor, topiroxostat, affected body weight. Male db/db mice were fed standard diets with or without topiroxostat for 4 week...
Autores principales: | Nakamura, Takashi, Nampei, Mai, Murase, Takayo, Satoh, Etsuko, Akari, Seigo, Katoh, Noriaki, Mizukami, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044114/ https://www.ncbi.nlm.nih.gov/pubmed/33850106 http://dx.doi.org/10.1038/s41387-021-00155-2 |
Ejemplares similares
-
The Effects of Topiroxostat, a Selective Xanthine Oxidoreductase Inhibitor, on Arterial Stiffness in Hyperuricemic Patients with Liver Dysfunction: A Sub-Analysis of the BEYOND-UA Study
por: Fujishima, Yuya, et al.
Publicado: (2023) -
Associations of circulating xanthine oxidoreductase activity with cardiometabolic risk markers in overweight and obese Japanese men: a cross-sectional pilot study
por: Kosaki, Keisei, et al.
Publicado: (2022) -
Systemic Endothelial Function, Plasma Xanthine Oxidoreductase Activity, and Blood Pressure Variability in Patients with Stable Coronary Artery Disease
por: Hiraga, Takashi, et al.
Publicado: (2022) -
Possible role of insulin resistance in activation of plasma xanthine oxidoreductase in health check-up examinees
por: Kurajoh, Masafumi, et al.
Publicado: (2022) -
Association between plasma xanthine oxidoreductase activity and in-hospital outcomes in patients with stable coronary artery disease after percutaneous coronary intervention
por: Sato, Ryota, et al.
Publicado: (2021)